$1.82
0.07[4.00%]
At close: Apr 22
$1.82
0[0.00%]
PreMarket: 7:05PM EDT
Cyclacel Pharmaceuticals
(NASDAQ:CYCC)Latest News for Cyclacel Pharmaceuticals Stock (NASDAQ:CYCC)
Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC)
Categories: All
Tuesday, April 16, 2024
Thursday, April 11, 2024
Monday, April 01, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Monday, January 15, 2024
Friday, January 12, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
- Cyclacel Pharmaceuticals shares are trading higher. The company announced it regained compliance with the Nasdaq minimum bid price requirement.Benzinga Newsdesk - Jan 8, 2024, 3:39PM
- Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Jan 8, 2024, 1:36PM
- Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price RequirementBenzinga Newsdesk - Jan 8, 2024, 9:26AM
- Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Jan 8, 2024, 8:20AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Jan 8, 2024, 8:05AM
Friday, January 05, 2024
Monday, December 25, 2023
Friday, December 22, 2023
- Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Dec 22, 2023, 1:28PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Dec 22, 2023, 12:31PM
- Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In NovemberAvi Kapoor - Dec 22, 2023, 9:40AM
- Why Cyclacel Pharmaceuticals (CYCC) Shares Are Getting ObliteratedHenry Khederian - Dec 22, 2023, 9:36AM
- Cyclacel Pharmaceuticals Announces $1.3M Registered Direct Offering Of Of 388,200 Shares At A Price Of $3.315 Per Share And Private Placement Offering Of 7,956 Shares Of Common Stock At A Purchase Price Of $3.315 Per ShareBenzinga Newsdesk - Dec 22, 2023, 9:19AM
Tuesday, December 19, 2023
Monday, December 18, 2023
Tuesday, December 12, 2023
Thursday, November 30, 2023
- Cyclacel Pharmaceuticals shares are trading higher after the company announced that it regained compliance with the Nasdaq.Benzinga Newsdesk - Nov 30, 2023, 10:56AM
- Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing Of Its Form 10-Q With The SECBenzinga Newsdesk - Nov 30, 2023, 9:19AM
- Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 30, 2023, 8:01AM